Ascelia Pharma - Recording of Q1-2025 presentation
Monday, May 19th, we hosted an event with Ascelia Pharma's Deputy CEO and CFO, Julie Waras Brogren. She presented the Q1 2025 report and key events during the quarter and post-closing. The presentation was followed by a Q&A session, where Julie Waras Brogren answered questions from the audience regarding the NDA filing for Orviglance, potential partnerships, and funding.
You can watch the recording here: Presentation Ascelia Pharma
Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma for a Digital IR subscription agreement. /Claus Thestrup 8:00 AM, 20/05/2025.
Login required
This content is only available for logged in users
